GSK-533

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGSK-533
Drug Alias NameGSK-533
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 4-kinase beta inhibitors
TargetsPhosphatidylinositol 4-kinase beta
Therapy Area/IndicationsEnterovirus 71 infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsEnterovirus 71 infection

Other Information

ATC CodeN/A
Related LinksN/A